Diabetes

Read our 2023 Year in Review to see our accomplishments over the past year as a global leader in diabetes research, patient care, and education.

Amber Van Den Heuvel received low-dose anti-thymocyte globulin (ATG) in 2015 as a participant in a TrialNet clinical study for people newly diagnosed with type 1 diabetes (T1D). Five years later, she still had beta cell function. Today, at age 26, Amber is encouraging people at high risk for T1D…

Check out the latest podcast featuring Dr. Michael Haller, Professor and Chief of Pediatric Endocrinology at UF Health Shands Hospital, discussing Screening for Type 1 Diabetes in the Primary Care Setting. Tune in here: https://files.radiomd.com/archives/uf_health_shands/ufhs096.mp3 #diabetes #t1d…

Exciting News!  Dr. Kimberly A. Driscoll, Ph.D., a leading expert in clinical and health psychology at @UF and UF Diabetes Institute Director…

Dr. Mark Atkinson is currently the American Diabetes Association Eminent Scholar for Diabetes Research at the University of Florida (UF), the Jeffrey Keene Family Professor, and the Director for the UF Diabetes Institute. The author of over 600 publications, 2023 marks his 40th year of investigation into the field of type…

UF Pediatric Endocrinology team ranked top 10 nationally   Please join us in congratulating the UF Pediatric Endocrinology team for their recognition as the highest-ranked specialty at UF Health Shands Children’s Hospital and as a top 10 nationally ranked program by U.S. News & World Report!  To read…

The UF Diabetes Institute is pleased to present the 2022 Year in Review, which serves as a reflection of our countless achievements throughout the past year, as a global leader in diabetes research, patient care, and education.

Join the UF Diabetes Institute for a seminar on November 14th from 12:00-1:00 p.m. Kathryn M. Ross., Ph.D., M.P.H., is an Associate Professor in the Department of Clinical & Health Psychology at the University of Florida. The seminar title is “Leveraging Technology to Improve Access to Behavioral Interventions for Obesity”.

Charlie khemtong, Ph.D., associate Professor in the Department of medicine at University of Florida. Seminar Title: “Carbon-13 Tracers: An Old Tool for New Metabolism Questions”. Oct 31th, 12-1p.m., Communicore…

  A major step toward transforming the understanding of cardiovascular and kidney disease in the millions of Americans with diabetes occurred Thursday when the National Institutes of Health designated the University of Florida Diabetes Institute the home for a new biobank of human heart and kidney tissue. A…